Overview

Rescue Therapy for Helicobacter Pylori Eradication

Status:
Recruiting
Trial end date:
2021-10-30
Target enrollment:
Participant gender:
Summary
Tetracycline and metronidazole based quadruple therapy had achieved a high cure rate in the rescue treatment of helicobacter pylori infection. This study aims to evaluate the efficacy and safety of the minocycline and metronidazole based bismuth quadruple therapy in the rescue treatment of helicobacter pylori infection.
Phase:
Phase 4
Details
Lead Sponsor:
Shanghai Jiao Tong University School of Medicine
Treatments:
Bismuth
Esomeprazole
Metronidazole
Minocycline
Potassium Citrate
Tetracycline